Ensysce Biosciences ENSC
NASDAQ ENSC
$0.52 +0.00 (+0.29%)
As of: Oct 22, 2026 · 12:28 PM EDT

Ensysce Biosciences (ENSC) Non-Current Deferred Tax Liability (2018 - 2019)

Updated

Ensysce Biosciences' Non-Current Deferred Tax Liability was $8,920 in Q3 2019, down 31.5% from the prior quarter.

Analysis

Ensysce Biosciences (ENSC) Non-Current Deferred Tax Liability (2018 - 2019) Analysis & Trends

At the end of FY2018, Non-Current Deferred Tax Liability at Ensysce Biosciences came in at $1,764.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,169.59 Bn 1,138.18 Bn 19.71 Bn
2 Johnson & Johnson 643.18 Bn 561.71 Bn 17.26 Bn
3 AbbVie 500.89 Bn 474.00 Bn 12.70 Bn
4 Merck 361.55 Bn 315.92 Bn 12.21 Bn
5 Novartis Ag 302.33 Bn 266.32 Bn 11.24 Bn
6 Astrazeneca 267.31 Bn 241.00 Bn 12.86 Bn
7 Amgen 241.52 Bn 196.92 Bn 7.24 Bn
8 Gilead Sciences 193.17 Bn 167.37 Bn 6.22 Bn
9 Pfizer 171.65 Bn 118.30 Bn 10.94 Bn
10 Ensysce Biosciences 1.33 Mn -9.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 8,920.00
Jun 30, 2019 13,014.00
Dec 31, 2018 1,764.00
API Access

Ensysce Biosciences Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=ENSC&period=max&api_key=YOUR_API_KEY